Alan Freidman | Vice President, Investor Relations |
Michael Dudley | Co-Founder, Chief Executive Officer, and Director |
Thomas Fitzgerald | Vice President and Chief Financial Officer |
Zdravka Medarova | Chief Technology Officer |
Hello, thank you for standing by and welcome to the TransCode Therapeutics Conference Call. At this time, all participants are in a listen only-mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Alan Freidman, Vice President of Investor Relations.